- •Preface
- •Contributors
- •Contents
- •Introduction
- •Literature Review
- •Major Issues
- •Major Studies
- •Negative Studies
- •References
- •1.1.1 Introduction
- •1.1.3 Torsional Ultrasound
- •1.1.4 Our Procedure for Emulsifying the Nucleus
- •References
- •1.2 Transitioning to Bimanual MICS
- •1.2.1 Introduction
- •1.2.2 Technique
- •1.2.3 Summary
- •1.3 0.7 mm Microincision Cataract Surgery
- •1.3.1 Sub 1 mm MICS: Why?
- •1.3.3 Instrumentation
- •1.3.3.2 0.7 mm Irrigating Instruments
- •1.3.4 Surgery
- •1.3.4.1 Incision
- •1.3.4.2 Capsulorhexis
- •1.3.4.3 Hydrodissection
- •1.3.4.4 Prechopping
- •1.3.5 0.7 mm MICS Combined Procedures
- •1.3.5.1 0.7 mm MICS and Glaucoma Surgery
- •1.3.6 Summary
- •References
- •2. MICS Instrumentation
- •2.1 MICS Instrument Choice: The First Step in the Transition
- •2.2 MICS Incision
- •2.3 MICS Capsulorhexis
- •2.4 MICS Prechopping
- •2.5 MICS Irrigation/Aspiration Instruments
- •2.5.1 19 G Instruments
- •2.5.2 21 G Instruments
- •2.6 MICS Auxiliary Instrument
- •2.6.1 Scissors
- •2.6.2 Gas Forced Infusion
- •2.6.3 Surge Prevention
- •2.7 New MICS Instruments
- •2.7.1 Flat Instruments
- •References
- •3.1 Introduction
- •3.2 Power Generation
- •3.3.1 Tuning
- •3.2.2 Phaco Energy
- •3.2.2.1 Low Frequency Energy
- •3.2.2.2 High Frequency Energy
- •3.2.3 Transient Cavitation
- •3.2.4 Sustained Cavitation
- •3.3.1 Alteration of Stroke Length
- •3.3.2 Alteration of Duration
- •3.3.2.1 Burst Mode
- •3.3.2.2 Pulse Mode
- •Micro Pulse (Hyper-Pulse)
- •Pulse Shaping
- •3.3.3 Alteration of Emission
- •3.4 Fluidics
- •3.5 Vacuum Sources
- •3.6 Surge
- •3.7.1 Micro-incisional Phaco
- •3.7.2 Bimanual Micro-Incisional Phaco
- •3.7.3 Micro-Incisional Coaxial Phaco
- •3.7.3.1 Irrigation and Aspiration
- •3.8 Conclusion
- •Reference
- •Further Reading
- •4.1 Introduction
- •4.3 Incision Size
- •4.4 Torsional Ultrasound
- •4.5 Conclusion
- •References
- •5. Technology Available
- •5.1 How to Better Use Fluidics with MICS
- •5.1.1 Physical Considerations
- •5.1.1.2 Chamber Stability
- •5.1.1.3 Holdability
- •5.1.2 Surgical Considerations
- •5.1.2.2 Phaco Technique
- •5.1.2.4 The OS3 and CataRhex SwissTech Platforms
- •Equipment
- •Machine Settings
- •5.2 How to Use Power Modulation in MICS
- •5.2.1 Introduction
- •5.2.3 The Concept of Unoccluded Flow Vacuum
- •5.2.4 The Intricacies of Ultrasound Power Modulation
- •5.2.5 The Variable Incidence of Wound Burn Rates
- •References
- •5.3 MICS with Different Platforms
- •5.3.1 MICS with the Accurus Surgical System
- •5.3.1.1 Introduction and Historic Background
- •5.3.1.3 Surgical Parameters for MICS with Accurus
- •5.3.1.4 Final Considerations
- •5.3.2.1 Introduction
- •5.3.2.7 Technology for MICS on the AMO Signature
- •5.3.2.8 Applying Signature Technology to CMICS and BMICS
- •5.3.3 MICS with Different Platforms: Stellaris Vision Enhancement System
- •5.3.3.2 Evaluating the Stellaris Vision Enhancement System
- •5.3.3.3 The Advantages of BMICS
- •References
- •6.1 Pupil Dilation and Preoperative Preparation
- •6.1.1 Managing the Small Pupil
- •6.1.2 Techniques that Depend on the Manipulation of the Pupil
- •6.1.3 Iris Surgery
- •6.1.4 Preoperative Preparation and Infection Prophylaxis
- •6.1.5 Evaluating Risk
- •6.1.6 Assessing Your Approach
- •6.1.7 Preventing Infection, Step by Step
- •6.1.8 Sample Protocol Outline
- •6.1.9 A Careful, Critical Eye
- •References
- •6.2 Incisions
- •References
- •6.3 Thermodynamics
- •6.3.1 Introduction
- •6.3.2 Corneal Thermal Damage
- •6.3.3 Heat Generation
- •6.3.4 Factors that Contribute to Thermal Incision Damage
- •6.3.4.1 Energy Emission: Amount and Pattern of How the Energy Is Delivered
- •6.3.4.3 Viscoelastic Devices and Possible Occlusion of the Aspiration Line
- •6.3.4.4 Irrigation Flow
- •6.3.4.5 Position of the Tip Inside the Incision
- •6.3.4.6 Tip Design
- •6.3.4.7 Surgical Technique
- •6.3.5 Conclusion
- •6.4 Using Ophthalmic Viscosurgical Devices with Smaller Incisions
- •6.4.1 Introduction
- •6.4.1.1 The Nature of OVDs: Rheology
- •6.4.1.3 Soft Shell and Ultimate Soft Shell Technique (SST & USST)
- •6.4.2 Routine, Special and complicated Cases
- •6.4.2.1 Phakic and Anterior Chamber IOLs
- •6.4.2.3 Fuchs’ Endothelial Dystrophy
- •6.4.2.5 Capsular Staining for White & Black Cataracts
- •6.4.2.6 Flomax® Intraoperative Floppy Iris Syndrome USST
- •6.4.3 Discussion
- •References
- •6.5 Capsulorhexis
- •References
- •References
- •6.7 Biaxial Microincision Cataract Surgery: Techniques and Sample Surgical Parameters
- •6.8.1 Surgical Technique
- •6.8.2 Advantages
- •6.8.3 Disadvantages
- •6.8.4 Final Thoughts
- •References
- •6.9 BiMICS vs. CoMICS: Our Actual Technique (Bimanual Micro Cataract Surgery vs. Coaxial Micro Cataract Surgery)
- •6.9.1 Introduction
- •6.9.2 Historical Background
- •6.9.3 BiMICS. BiManual MicroIncision Cataract Surgery
- •6.9.3.1 Introduction
- •6.9.3.2 Instrumentation
- •6.9.3.5 Phacotips
- •6.9.3.6 Capsulorhexis
- •6.9.3.7 Phaco Knives
- •6.9.3.8 The Phaco Machines
- •6.9.3.9 Phaco Pumps
- •6.9.3.10 Ultrasound Power Delivery
- •6.9.3.11 IOL Implantation
- •6.9.3.12 Astigmatism
- •6.9.4.1 Capsulorhexis
- •6.9.4.2 Phacotips
- •6.9.4.3 The Phaco Machines
- •6.9.4.4 Phaco Pumps
- •6.9.4.5 Ultrasound Power Delivery
- •6.9.4.6 Irrigation-Aspiration
- •6.9.4.7 Incision-Assisted IOL Implantation
- •6.9.5 Conclusion
- •References
- •6.10 Endophthalmitis Prevention
- •6.10.1 Antibiotic Prophylaxis
- •6.10.2 Wound Construction
- •6.10.3 Summary
- •References
- •7.1 High Myopia
- •7.2 Posterior Polar Cataract
- •7.3 Posterior Subluxed Cataracts
- •7.4 Mature Cataract with Zonular Dialysis
- •7.5 Punctured Posterior Capsule
- •7.6 Posterior Capsule Rupture
- •7.7 Pseudoexfoliation
- •7.8 Rock-Hard Nuclei
- •7.9 Switching Hands
- •7.10 Microcornea or Microphthalmos
- •7.11 Large Iridodialysis and Zonular Defects
- •7.12 Intraoperative Floppy Iris Syndrome (IFIS)
- •7.14 Iris Bombé
- •7.15 Very Shallow Anterior Chambers
- •7.16 Refractive Lens Exchange
- •7.18 Intraocular Cautery
- •7.19 Biaxial Microincision Instruments
- •References
- •7.1 MICS in Special Cases: Incomplete Capsulorhexis
- •7.1.1 Introduction
- •7.1.2 Avoiding Complications While Constructing Your Microcapsulorhexis
- •7.1.3 Avoiding Complications During Biaxial Phaco with an Incomplete Capsulorhexis
- •7.1.4 Avoiding Complications During IOL Insertion with an Incomplete Capsulorhexis
- •7.1.5 Conclusions
- •References
- •7.2 MICS in Special Cases (on CD): Vitreous Loss
- •7.2.1 Introduction
- •7.2.2 Posterior Capsule Tears and Vitreous Prolapse
- •7.2.3 Vitreous and the Epinucleus or Cortex
- •7.2.4 Different Techniques Other than Pars Plana Vitrectomy for Nuclear Loss in Vitreous
- •7.2.5 Pars Plana Vitrectomy
- •7.2.6 Zonulolysis
- •References
- •7.3 How to Deal with Very Hard and Intumescent Cataracts
- •7.3.1 Introduction
- •7.3.2 Types of Cataracts
- •7.3.3 Management of Hard Cataracts Through Biaxial Technique
- •7.3.4 Incision
- •7.3.5 Capsulorrhexis
- •7.3.6 Hydrodissection
- •7.3.8 Conclusion
- •References
- •8. IOL Types and Implantation Techniques
- •8.1 MICS Intraocular Lenses
- •8.1.1 Introduction
- •8.1.2 Lenses
- •8.1.2.2 ThinOptX MICS IOLs (ThinOptX, Abingdon, VA)
- •8.1.2.3 Akreos MI60 AO Micro Incision IOL (Bausch & Lomb, Rochester, NY)
- •8.1.2.4 IOLtech MICS lens (IOLtech, La Rochelle, France; and Carl Zeiss Meditec, Stuttgard, Germany)
- •8.1.3 Optical Quality of MICS IOLs
- •8.1.4 Conclusion
- •References
- •8.2 Implantation Techniques
- •8.2.2 Prerequisites to a Sub-2 Injection
- •8.2.3 IOLs Used for Injection Through Microincision
- •8.2.3.1 Material
- •8.2.3.2 Design
- •8.2.3.3 Optic Design
- •8.2.3.4 Haptic Design
- •8.2.3.5 Posterior Barrier (360°)
- •8.2.4 Injectors Meant for Microincision
- •8.2.4.1 Objectives of Injectors Meant for Microincision
- •8.2.4.2 Characteristics of Sub-2 Injectors
- •8.2.4.3 The Cartridges
- •Loading Chambers
- •Injection Tunnels and Cartridge Tips
- •8.2.4.4 The Plunger Tips (or plunger)
- •8.2.4.5 Pushing Systems
- •8.2.4.6 Injector Bodies
- •8.2.4.7 Principal Sub-2 Injectors
- •8.2.5 Visco Elastic Substances and Injection Through Microincision
- •8.2.6 Techniques of Sub-2 Injection
- •8.2.6.2 Incision Construction
- •8.2.6.3 Pressurization of the Anterior Chamber
- •8.2.6.4 Loading the Cartridge
- •8.2.6.5 Loading the Injector
- •8.2.6.6 Insertion of the Plunger Tip
- •8.2.6.7 Injection in the Anterior Chamber
- •8.2.6.8 Positioning the IOL in the Capsular Bag
- •8.2.6.9 Removing the VES
- •8.2.6.10 Thin Roller Injector
- •8.2.6.11 Conclusion
- •Reference
- •8.3 Special Lenses
- •8.3.1 Toric Posterior Chamber Intraocular Lenses in Cataract Surgery and Refractive Lens Exchange
- •8.3.1.1 Introduction
- •8.3.1.3 T-IOL Calculation
- •8.3.1.4 Current T-IOL Models
- •8.3.1.5 Preoperative Marking
- •8.3.1.6 Clinical Indications
- •8.3.1.7 Custom-Made Lenses
- •8.3.1.8 Conclusion for Practice
- •References
- •8.3.2 Special Lenses: MF
- •8.3.2.1 Discussion
- •8.3.2.2 Conclusion
- •8.3.2.3 Outlook
- •References
- •8.3.3 Special Lenses: Aspheric
- •References
- •8.3.4 Intraocular Lenses to Restore and Preserve Vision Following Cataract Surgery
- •8.3.4.1 Introduction
- •8.3.4.2 Why Filter Blue Light?
- •Summary
- •8.3.4.3 Importance of Blue Light to Cataract and Refractive Lens Exchange Patients
- •Summary
- •8.3.4.4 Quality of Vision with Blue Light Filtering IOLs
- •Summary
- •8.3.4.5 Clinical Experience
- •Summary
- •8.3.4.6 Unresolved Issues and Future Considerations
- •References
- •8.3.5 Microincision Intraocular Lenses: Others
- •8.3.5.1 ThinOptX®
- •8.3.5.2 Smart IOL
- •8.3.5.4 AcriTec
- •8.3.5.5 Akreos
- •8.3.5.7 Rayner
- •8.3.5.8 Injectable Polymers
- •8.3.5.9 Final Comments
- •References
- •9. Outcomes
- •9.1 Safety: MICS versus Coaxial Phaco
- •9.1.1 Introduction
- •9.1.2 Visual Outcomes
- •9.1.3 Incision Damage
- •9.1.4 Corneal Incision Burn
- •9.1.5 Corneal Changes
- •9.1.6 Infection
- •9.1.7 Summary
- •References
- •9.2 Control of Corneal Astigmatism and Aberrations
- •9.2.1 Introduction: Impacts of MICS Incision on the Outcomes of Cataract Surgery
- •9.2.2 Objective Evaluation of Corneal Incision
- •9.2.3 Control of Corneal Aberration and Astigmatism with MICS
- •9.2.4 Role of Corneal Aberrometry in Evaluating MICS Incision
- •9.2.5 Role of OCT in Evaluating MICS Incision
- •9.2.6 Our Experience in Corneal Aberrations and Astigmatism After MICS
- •9.2.7 Conclusion
- •References
- •9.3 Corneal Endothelium and Other Safety Issues
- •9.4 Incision Quality in MICS
- •9.4.1 Introduction: History of Incision Size Reduction
- •9.4.2 The Trends Towards Microincision Cataract Surgery (BMICS)
- •9.4.3 Advantages of Minimizing the Incision Size
- •9.4.4 Model for the Analysis of Corneal Incision Quality [21]
- •9.4.5 Our Protocol for Evaluation of Incision Quality in BMICS [21]
- •9.4.6 Results
- •9.4.6.1 Visual, Refractive and Biomicroscopic Outcomes
- •9.4.6.2 Incision Imaging (OCT) Outcomes
- •9.4.8 Conclusion
- •References
- •INDEX
6.4 Using Ophthalmic Viscosurgical Devices with Smaller Incisions |
131 |
2. Viscoadaptive |
|
|
filled space |
3. BSS filled |
|
(injected second) |
space |
|
1. Viscoat |
||
(injected third) |
||
filled space |
||
|
||
(injected first) |
|
Incision
Fig. 6.43 Modified SST-USST for IFIS. The Flomax IFIS SST-USST
Arshinoff 2.7mm soft-shoulder diamond knife (Diamond Surgical Products), trying to lengthen the tunnel such that the corneal internal entry is slightly central to the papillary margin. The width of the knife is significant in that both incisions are intentionally tight in order to prevent leakage and iris prolapse.
3.The AC is then filled, through the phaco incision, with Viscoat (Alcon Laboratories, Fort Worth, TX), until the AC is about 70% full. Healon5 is then injected onto the surface of the anterior lens capsule, in the center of the AC, and it proceeds, pushing the Viscoat upwards and outwards, until the pupil stops dilating. It is important that the boundary of the Healon5/Viscoat be at the pupillary margin. This will later serve as a fracture boundary, and will help to keep the iris stable, and the pupil dilated, throughout the surgery. At this point the AC should be, over 90%, full of OVD and the eye should feel slightly firm. This step is a variation of SST.
4.BSS, or some of the nonpreserved lidocaine or phenylephrine is then injected slowly under the Healon5 layer, on the surface of the lens capsule, with the cannula aperture placed at the very center of the lens surface, to elevate the OVD soft shell, which is created above, off the lens surface, and create a water pocket on the lenticular surface which is confined to the lenticular surface, and not spilling over the iris surface. This is a variation of USST.
5.A routine capsulorhexis is then performed using a bent needle, beginning at the center of the lens, and being sure to keep the diameter of the capsulorhexis smaller than the pupil diameter. This will later act to confine the fluid flow into an area smaller than
the pupil, preventing turbulence from impacting the iris and the Viscoat layer, which would permit the pupil to constrict.
6.Hydrodissection is then performed with BSS on a 10 mL syringe with a 27 gauge hockey stick cannula, using small short pulses of BSS. As long as care is taken in performing the steps above, as well as in the placement of the BSS cannula, the BSS should be able to circulate around the lens and flow out of the eye, beneath the OVD shell, without disturbing the shell. If the OVD shell is disturbed in this step, and some OVD is lost, Healon5 is reinjected followed by BSS below it, before proceeding.
7.The Alcon Infiniti Phaco (or similar peristaltic) machine settings are adjusted to flow ≤20mL/min, vacuum ≤250mmHg, bottle height 75–80cm above patient’s eye, linear variable pulse mode. The procedure is performed using Phaco Slice & Separate or similar chopping technique, being sure to keep the Phaco tip at or below the capsulorhexis, and confining the fluid flow into the capsular bag [17]. All work is done in the capsular bag, and attempts to only engage the phaco into positions 1, 2 or 3 are made only with the phaco in the bag, and a piece of nucleus engaged. Unnecessary irrigation of the AC is avoided.
When the above steps are followed, paying careful attention to measuring the pupils preoperatively and creating tight incisions, Flomax cases become relatively routine procedures.
6.4.3 Discussion
Modern cataract surgery has brought modern challenges, due to new devices, methods, and patient medical status, and complicating systemic drugs. The recent move to smaller incision surgery, in the range of 2 mm, whether biaxial or coaxial, has changed our rheologic approach to phacoemulsification, but renewed attention is needed to understand what we are trying to do rheologically in different circumstances, and how the smaller incisions affect the rheological behavior of our OVDs, both in their surgical use and in later removal. A good understanding of rheological principles, however, in our new tighter environment, which in reality is changed only slightly from 3 mm incisions, can be used to create
132 |
S. A. Arshinoff |
any physical environment that we can invent, limited only by our imaginations. Cataract surgery really is just the application of rheology. The only two factors that make a difference in phacoemulsification are phaco power modulations, and our manipulation of the flow parameters (rheology) of our surgery. Rheology is by general consensus, a difficult subject, but understanding it, and its applications, makes us much better cataract surgeons, in any incisional environment.
Take Home Pearls
ßSmaller incisions make us less dependent upon high zero shear viscosity to maintain spaces, but
once an instrument is inserted into the eye, lower viscosity dispersives begin to leak out, destabilizing the created surgical microenvironment.
ßIn special situations, with anticipated difficult OVD removal (phakic IOLs, AC IOLs), visco-
adaptives are not the best choice of OVDs.
ßPreoperative dilation test should be used for all Flomax cases. If the pupil dilates to > 6.5 mm,
the case will not be difficult. If however, it dilates to <5.5 mm, difficulty can be anticipated and the IFIS SST-USST technique is used.
ßSmaller incisions generally make OVD techniques more stable and easier to perform.
References
1.Balazs EA (1979) Ultrapure hyaloronic acid and the use thereof. US Patent No. 4.141.973
2.Arshinoff SA (1995) Dispersive and cohesive viscoelastic materials in phacoemulsification. Ophthalmic Pract 13:98–104
3.Arshinoff SA (1999) Dispersive-cohesive viscoelastic soft shell technique. J Cataract Refract Surg 25:167–173
4.Arshinoff SA (1989) Comparative physical properties of ophthalmic viscoelastic materials. Ophthalmic Pract 1:16– 19; 36–37
5.Arshinoff S (1994) Dispersive and cohesive viscoelastic materials in phacoemulsification. In: Solomon L (ed) Ophthalmic Advisory Panel at the ASCRS, Boston, MA. Medicopea international, Montreal, pp 28–40
6.Arshinoff Steve A (1998) Healon5 entering selected countries in Europe. Ocular Surgery News, International Ed 9:11–12.
7.Arshinoff Steve A, Jafari Masoud A (2005) A new classification of ophthalmic viscosurgical devices (OVDs) 2005. J Cataract Refract Surg 31:2167–2171
8.Arshinoff Steve A (1999) Dispersive-cohesive viscoelastic soft shell technique. J Cataract Refract Surg 25:167–173
9.Arshinoff Steve A (2002) Using BSS with viscoadaptives in the ultimate soft-shell technique. J Cataract Refract Surg 28(9):1509–1514
10.Arshinof et al FDA metaanalysis study of OVDs. Unpublished data on record
11.Wollensak G, Spörl E, Pham D-T (2004) Biomechanical changes in the anterior lens capsule after trypan blue staining. J Cataract Refract Surg 30:1526–1530
12.Dick HB, Aliyeva SE, Hengerer F (2008) Effect of trypan blue on the elasticity of the human anterior leens capsule. J Cataract Refract Surg 34:1367–1373
13.Arshinoff Steve A (2005) Letter. Capsular dyes and the USST. J Cataract Refract Surg 31:259–260
14.Marques DM, Marques FF, Osher RH (2004) Three-step technique for staining the anterior lens capsule with indocyanine green or trypan blue. J Cataract Refract Surg 30(1):13–16
15.Yetil H, Devranoglu K, Ozkan S (2002) Determining the lowest trypan blue concentration that satisfactorily stains the anterior capsule. J Cataract Refract Surg 28(6):988–991
16.Arshinoff SA (2006) Modified SST–USST for tamsulosinassociated intraocular floppy-iris syndrome. J Cataract Refract Surg 32:559–561 (erratum, 32(7):1076)
17.Arshinoff Steve A (1999) Phaco slice and separate. J Cataract Refract Surg 4:474–478
